Growth-Hormone-Releasing Hormone: A Clinical Update

  1. MARY LEE VANCE, M.D.; and
  2. MICHAEL O. THORNER, M.B., F.R.C.P.
  1. University of Virginia Medical Center,
    Charlottesville, Virginia

    Excerpt

    Growth-hormone-releasing hormone (GHRH) is the most recent and last of the classical hypothalamic releasing hormones to be identified. The discovery and characterization of a new hormone affords the scientific and medical community the opportunity to address several questions of potential physiologic and practical importance, as the work with GHRH amply shows. First, it is necessary to determine the in-vitro and in-vivo action, specificity, interaction with other hormones, and any invivo adverse effects. If the hormone is shown to have diagnostic or therapeutic benefit, it may then be made available for general clinical use. At this time in the United States,

    This 100-word excerpt has been provided in the absence of an abstract.

    Acknowledgments

    ACKNOWLEDGMENTS: Grant support: in part by grants HD17120 (Dr. Vance) and AM32632 and RR0847 (Dr. Thorner) from the National Institutes of Health.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement